肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南 - Suppr

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

作者信息

Marrero Jorge A, Kulik Laura M, Sirlin Claude B, Zhu Andrew X, Finn Richard S, Abecassis Michael M, Roberts Lewis R, Heimbach Julie K

机构信息

UT Southwestern Medical Center, Dallas, TX.

Northwestern Medicine, Chicago, IL.

出版信息

Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.

DOI:10.1002/hep.29913

PMID:29624699

Abstract

摘要

相似文献

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南

Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.

From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.从肝癌的诊断到治疗：发达国家和发展中国家共同面临的流行问题。

World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282.

Management of hepatocellular carcinoma in the age of liver transplantation.肝移植时代肝细胞癌的管理

Int J Surg. 2009 Aug;7(4):324-9. doi: 10.1016/j.ijsu.2008.12.041. Epub 2009 Jan 6.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肝细胞癌：ESMO 诊断、治疗及随访临床实践指南

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308.

Hepatocellular carcinoma in children.儿童肝细胞癌。

Clin Liver Dis. 2015 May;19(2):433-47. doi: 10.1016/j.cld.2015.01.010. Epub 2015 Feb 28.

Hepatocellular carcinoma: current approaches to diagnosis and management.肝细胞癌：当前的诊断与管理方法

Intern Med J. 2002 Aug;32(8):394-400. doi: 10.1046/j.1445-5994.2002.00227.x.

[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].《中国原发性肝癌诊疗规范（2019年版）》

Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):112-128. doi: 10.3760/cma.j.issn.1007-3418.2020.02.004.

Advances in Hepatocellular Carcinoma.肝细胞癌的进展

Clin Liver Dis. 2020 Nov;24(4):xiii-xiv. doi: 10.1016/j.cld.2020.08.014.

[Prospect of hepatocellular carcinoma in 2008].[2008年肝细胞癌的前景]

Zhonghua Gan Zang Bing Za Zhi. 2009 Jan;17(1):7-9.

Hepatocellular carcinoma: Present and future.肝细胞癌：现状与未来。

Med Clin (Barc). 2018 May 23;150(10):390-397. doi: 10.1016/j.medcli.2017.08.010. Epub 2017 Oct 31.

引用本文的文献

Identifying determinants of viral hepatitis and liver cancer care in Michigan Asian American communities through multilevel engagement.通过多层次参与确定密歇根州亚裔美国人社区病毒性肝炎和肝癌护理的决定因素。

Hepatol Commun. 2025 Sep 5;9(9). doi: 10.1097/HC9.0000000000000803. eCollection 2025 Sep 1.

In-situ-formed TCM-inspired dual-function nanocomposite hydrogel for intraoperative hemostasis and postoperative recurrence prevention in hepatocellular carcinoma.用于肝细胞癌术中止血及术后复发预防的原位形成的中医启发式双功能纳米复合水凝胶

Mater Today Bio. 2025 Aug 13;34:102192. doi: 10.1016/j.mtbio.2025.102192. eCollection 2025 Oct.

CT-based deep learning radiomics model for predicting proliferative hepatocellular carcinoma: application in transarterial chemoembolization and radiofrequency ablation.基于CT的深度学习影像组学模型预测增殖性肝细胞癌：在经动脉化疗栓塞和射频消融中的应用

BMC Med Imaging. 2025 Sep 1;25(1):363. doi: 10.1186/s12880-025-01913-9.

Bicarbonate-integrated transarterial chemoembolization (TACE) in real-world hepatocellular carcinoma.现实世界中肝细胞癌的碳酸氢盐整合经动脉化疗栓塞术（TACE）

Signal Transduct Target Ther. 2025 Sep 1;10(1):281. doi: 10.1038/s41392-025-02400-x.

Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target.将奈玛特韦重新用于治疗肝细胞癌：网络药理学和分子动力学模拟确定HDAC3为关键分子靶点。

Pharmaceuticals (Basel). 2025 Jul 31;18(8):1144. doi: 10.3390/ph18081144.

Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Hepatocellular Carcinoma: A Review of Emerging Applications for Locoregional Therapy.肝细胞癌的定量动态对比增强磁共振成像（DCE-MRI）：局部区域治疗新兴应用综述

Bioengineering (Basel). 2025 Aug 12;12(8):870. doi: 10.3390/bioengineering12080870.

Revisiting the role of local treatments in the era of targeted therapy and immunotherapy for hepatocellular carcinoma.重新审视局部治疗在肝细胞癌靶向治疗和免疫治疗时代的作用。

World J Surg Oncol. 2025 Aug 27;23(1):323. doi: 10.1186/s12957-025-03963-3.

A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma.一种基于血清肿瘤坏死因子受体2（TNFR2）的模型可有效预测术前微血管侵犯，并对肝细胞癌的肿瘤复发风险进行分层。

BMC Gastroenterol. 2025 Aug 27;25(1):622. doi: 10.1186/s12876-025-04152-y.

Current knowledge about immunotherapy response after liver transplantation of patients with liver cancer.关于肝癌患者肝移植后免疫治疗反应的当前知识。

J Liver Transpl. 2025 Aug;19. doi: 10.1016/j.liver.2025.100285. Epub 2025 Jun 6.

Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombus.同步放疗与免疫治疗用于伴有广泛门静脉肿瘤血栓的不可切除肝细胞癌

Adv Radiat Oncol. 2025 Jul 12;10(10):101856. doi: 10.1016/j.adro.2025.101856. eCollection 2025 Oct.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献